Necrolytic Migratory Erythema Associated With a Metastatic Neuroendocrine Tumor

Article Type
Article
Changed
Thu, 01/10/2019 - 12:21
Display Headline
Necrolytic Migratory Erythema Associated With a Metastatic Neuroendocrine Tumor
Author(s)
Lolis MS
Krishtul A
Vidal C
Shim-Chang H
Phelps R
Lebwohl M
Article PDF
087020078.pdf
Issue
Cutis - 87(2)
Publications
Cutis
MDedge Dermatology
Topics
Contact Dermatitis
Page Number
78-80
Author(s)
Lolis MS
Krishtul A
Vidal C
Shim-Chang H
Phelps R
Lebwohl M
Author(s)
Lolis MS
Krishtul A
Vidal C
Shim-Chang H
Phelps R
Lebwohl M
Article PDF
087020078.pdf
Article PDF
087020078.pdf
Issue
Cutis - 87(2)
Issue
Cutis - 87(2)
Page Number
78-80
Page Number
78-80
Publications
Cutis
MDedge Dermatology
Publications
Cutis
MDedge Dermatology
Topics
Contact Dermatitis
Article Type
Article
Display Headline
Necrolytic Migratory Erythema Associated With a Metastatic Neuroendocrine Tumor
Display Headline
Necrolytic Migratory Erythema Associated With a Metastatic Neuroendocrine Tumor
Disallow All Ads
Alternative CME
Article PDF Media

Calcitriol Ointment 3 μg/g Is Safe and Effective Over 52 Weeks for the Treatment of Mild to Moderate Plaque Psoriasis

Article Type
Article
Changed
Thu, 12/15/2022 - 15:12
Display Headline
Calcitriol Ointment 3 μg/g Is Safe and Effective Over 52 Weeks for the Treatment of Mild to Moderate Plaque Psoriasis
Author(s)
Lebwohl M
Ortonne J-P
Andres P
Briantais P

Article PDF
083040205.pdf
Author and Disclosure Information

Lebwohl M, Ortonne J-P, Andres P, Briantais P

Issue
Cutis - 83(4)
Publications
Cutis
MDedge Dermatology
Psoriasis Collection
B-Cell Lymphoma ICYMI
Breast Cancer ICYMI
Topics
Psoriasis
Page Number
205-212
Sections
Original Research
Clinical Topics & News
Author(s)
Lebwohl M
Ortonne J-P
Andres P
Briantais P
Author(s)
Lebwohl M
Ortonne J-P
Andres P
Briantais P
Author and Disclosure Information

Lebwohl M, Ortonne J-P, Andres P, Briantais P

Author and Disclosure Information

Lebwohl M, Ortonne J-P, Andres P, Briantais P

Article PDF
083040205.pdf
Article PDF
083040205.pdf

Issue
Cutis - 83(4)
Issue
Cutis - 83(4)
Page Number
205-212
Page Number
205-212
Publications
Cutis
MDedge Dermatology
Psoriasis Collection
B-Cell Lymphoma ICYMI
Breast Cancer ICYMI
Publications
Cutis
MDedge Dermatology
Psoriasis Collection
B-Cell Lymphoma ICYMI
Breast Cancer ICYMI
Topics
Psoriasis
Article Type
Article
Display Headline
Calcitriol Ointment 3 μg/g Is Safe and Effective Over 52 Weeks for the Treatment of Mild to Moderate Plaque Psoriasis
Display Headline
Calcitriol Ointment 3 μg/g Is Safe and Effective Over 52 Weeks for the Treatment of Mild to Moderate Plaque Psoriasis
Sections
Original Research
Clinical Topics & News
Article Source

PURLs Copyright

Inside the Article

Article PDF Media

A New Standardized Method of Evaluating Cutaneous Irritation From Topical Medications

Article Type
Article
Changed
Thu, 12/15/2022 - 15:12
Display Headline
A New Standardized Method of Evaluating Cutaneous Irritation From Topical Medications
Author(s)
Uliasz A
Lebwohl M

Article PDF
082010075.pdf
Author and Disclosure Information

Uliasz A, Lebwohl M

Issue
Cutis - 82(1)
Publications
Cutis
MDedge Dermatology
Psoriasis Collection
B-Cell Lymphoma ICYMI
Breast Cancer ICYMI
Topics
Contact Dermatitis
Atopic Dermatitis
Psoriasis
Page Number
75-77
Sections
Original Research
Clinical Topics & News
Author(s)
Uliasz A
Lebwohl M
Author(s)
Uliasz A
Lebwohl M
Author and Disclosure Information

Uliasz A, Lebwohl M

Author and Disclosure Information

Uliasz A, Lebwohl M

Article PDF
082010075.pdf
Article PDF
082010075.pdf

Issue
Cutis - 82(1)
Issue
Cutis - 82(1)
Page Number
75-77
Page Number
75-77
Publications
Cutis
MDedge Dermatology
Psoriasis Collection
B-Cell Lymphoma ICYMI
Breast Cancer ICYMI
Publications
Cutis
MDedge Dermatology
Psoriasis Collection
B-Cell Lymphoma ICYMI
Breast Cancer ICYMI
Topics
Contact Dermatitis
Atopic Dermatitis
Psoriasis
Article Type
Article
Display Headline
A New Standardized Method of Evaluating Cutaneous Irritation From Topical Medications
Display Headline
A New Standardized Method of Evaluating Cutaneous Irritation From Topical Medications
Sections
Original Research
Clinical Topics & News
Article Source

PURLs Copyright

Inside the Article

Article PDF Media

A Single-Center, Double-Blind, Randomized Trial of the Atrophogenic Effects of Fluocinonide Cream 0.1% Versus Clobetasol Propionate Cream 0.05% in Participants With Corticosteroid-Responsive Dermatoses

Article Type
Article
Changed
Thu, 12/15/2022 - 15:12
Display Headline
A Single-Center, Double-Blind, Randomized Trial of the Atrophogenic Effects of Fluocinonide Cream 0.1% Versus Clobetasol Propionate Cream 0.05% in Participants With Corticosteroid-Responsive Dermatoses
Author(s)
Uliasz A
Zeichner J
Soung J
Wong V
Lebwohl M

Article PDF
081060517.pdf
Author and Disclosure Information

Uliasz A, Zeichner J, Soung J, Wong V, Lebwohl M

Issue
Cutis - 81(6)
Publications
Cutis
MDedge Dermatology
Psoriasis Collection
B-Cell Lymphoma ICYMI
Breast Cancer ICYMI
Topics
Contact Dermatitis
Atopic Dermatitis
Psoriasis
Page Number
517-519
Sections
Original Research
Clinical Topics & News
Author(s)
Uliasz A
Zeichner J
Soung J
Wong V
Lebwohl M
Author(s)
Uliasz A
Zeichner J
Soung J
Wong V
Lebwohl M
Author and Disclosure Information

Uliasz A, Zeichner J, Soung J, Wong V, Lebwohl M

Author and Disclosure Information

Uliasz A, Zeichner J, Soung J, Wong V, Lebwohl M

Article PDF
081060517.pdf
Article PDF
081060517.pdf

Issue
Cutis - 81(6)
Issue
Cutis - 81(6)
Page Number
517-519
Page Number
517-519
Publications
Cutis
MDedge Dermatology
Psoriasis Collection
B-Cell Lymphoma ICYMI
Breast Cancer ICYMI
Publications
Cutis
MDedge Dermatology
Psoriasis Collection
B-Cell Lymphoma ICYMI
Breast Cancer ICYMI
Topics
Contact Dermatitis
Atopic Dermatitis
Psoriasis
Article Type
Article
Display Headline
A Single-Center, Double-Blind, Randomized Trial of the Atrophogenic Effects of Fluocinonide Cream 0.1% Versus Clobetasol Propionate Cream 0.05% in Participants With Corticosteroid-Responsive Dermatoses
Display Headline
A Single-Center, Double-Blind, Randomized Trial of the Atrophogenic Effects of Fluocinonide Cream 0.1% Versus Clobetasol Propionate Cream 0.05% in Participants With Corticosteroid-Responsive Dermatoses
Sections
Original Research
Clinical Topics & News
Article Source

PURLs Copyright

Inside the Article

Article PDF Media

Calcinosis Cutis in a Patient With Eosinophilia-Myalgia Syndrome: Case Report

Article Type
Article
Changed
Thu, 01/10/2019 - 12:07
Display Headline
Calcinosis Cutis in a Patient With Eosinophilia-Myalgia Syndrome: Case Report
Author(s)
Smith E
Gordon M
Lebwohl M
Article PDF
077060361.pdf
Author and Disclosure Information

 

Smith E, Gordon M, Lebwohl M

Issue
Cutis - 77(6)
Publications
Cutis
MDedge Dermatology
Page Number
361-364
Author(s)
Smith E
Gordon M
Lebwohl M
Author(s)
Smith E
Gordon M
Lebwohl M
Author and Disclosure Information

 

Smith E, Gordon M, Lebwohl M

Author and Disclosure Information

 

Smith E, Gordon M, Lebwohl M

Article PDF
077060361.pdf
Article PDF
077060361.pdf
Issue
Cutis - 77(6)
Issue
Cutis - 77(6)
Page Number
361-364
Page Number
361-364
Publications
Cutis
MDedge Dermatology
Publications
Cutis
MDedge Dermatology
Article Type
Article
Display Headline
Calcinosis Cutis in a Patient With Eosinophilia-Myalgia Syndrome: Case Report
Display Headline
Calcinosis Cutis in a Patient With Eosinophilia-Myalgia Syndrome: Case Report
Disallow All Ads
Article PDF Media

Tacrolimus Ointment in the Treatment of Eyelid Dermatitis

Article Type
Article
Changed
Thu, 01/10/2019 - 12:01
Display Headline
Tacrolimus Ointment in the Treatment of Eyelid Dermatitis
Author(s)
Freeman AK
Serle J
Vanveldhuisen P
Lind L
Clarke J
Singer G
Lebwohl M

Article PDF
073040267.pdf
Author and Disclosure Information

Freeman AK, Serle J, VanVeldhuisen P, Lind L, Clarke J, Singer G, Lebwohl M

Issue
Cutis - 73(4)
Publications
Cutis
MDedge Dermatology
Topics
Contact Dermatitis
Page Number
267-271
Sections
Original Research
Author(s)
Freeman AK
Serle J
Vanveldhuisen P
Lind L
Clarke J
Singer G
Lebwohl M
Author(s)
Freeman AK
Serle J
Vanveldhuisen P
Lind L
Clarke J
Singer G
Lebwohl M
Author and Disclosure Information

Freeman AK, Serle J, VanVeldhuisen P, Lind L, Clarke J, Singer G, Lebwohl M

Author and Disclosure Information

Freeman AK, Serle J, VanVeldhuisen P, Lind L, Clarke J, Singer G, Lebwohl M

Article PDF
073040267.pdf
Article PDF
073040267.pdf

Issue
Cutis - 73(4)
Issue
Cutis - 73(4)
Page Number
267-271
Page Number
267-271
Publications
Cutis
MDedge Dermatology
Publications
Cutis
MDedge Dermatology
Topics
Contact Dermatitis
Article Type
Article
Display Headline
Tacrolimus Ointment in the Treatment of Eyelid Dermatitis
Display Headline
Tacrolimus Ointment in the Treatment of Eyelid Dermatitis
Sections
Original Research
Article Source

PURLs Copyright

Inside the Article

Article PDF Media

Efficacy and Safety of Terbinafine 1% Solution in the Treatment of Interdigital Tinea Pedis and Tinea Corporis or Tinea Cruris

Article Type
Article
Changed
Thu, 01/10/2019 - 11:50
Display Headline
Efficacy and Safety of Terbinafine 1% Solution in the Treatment of Interdigital Tinea Pedis and Tinea Corporis or Tinea Cruris
Author(s)
Lebwohl M
Elewski B
Eisen D
Savin RC

Article PDF
067030261.pdf
Author and Disclosure Information

Lebwohl M, Elewski B, Eisen D, Savin RC, The Terbinafine 1% Solution Group (SFF-351)

Issue
Cutis - 67(3)
Publications
Cutis
MDedge Dermatology
Topics
Infectious Diseases
Page Number
261-266
Sections
Original Research
Author(s)
Lebwohl M
Elewski B
Eisen D
Savin RC
Author(s)
Lebwohl M
Elewski B
Eisen D
Savin RC
Author and Disclosure Information

Lebwohl M, Elewski B, Eisen D, Savin RC, The Terbinafine 1% Solution Group (SFF-351)

Author and Disclosure Information

Lebwohl M, Elewski B, Eisen D, Savin RC, The Terbinafine 1% Solution Group (SFF-351)

Article PDF
067030261.pdf
Article PDF
067030261.pdf

Issue
Cutis - 67(3)
Issue
Cutis - 67(3)
Page Number
261-266
Page Number
261-266
Publications
Cutis
MDedge Dermatology
Publications
Cutis
MDedge Dermatology
Topics
Infectious Diseases
Article Type
Article
Display Headline
Efficacy and Safety of Terbinafine 1% Solution in the Treatment of Interdigital Tinea Pedis and Tinea Corporis or Tinea Cruris
Display Headline
Efficacy and Safety of Terbinafine 1% Solution in the Treatment of Interdigital Tinea Pedis and Tinea Corporis or Tinea Cruris
Sections
Original Research
Article Source

PURLs Copyright

Inside the Article

Article PDF Media
Subscribe to Lebwohl M